Gregory M. Mayhew

1.4k total citations
19 papers, 894 citations indexed

About

Gregory M. Mayhew is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Gregory M. Mayhew has authored 19 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Neurology. Recurrent topics in Gregory M. Mayhew's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Gregory M. Mayhew is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Fibroblast Growth Factor Research (4 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Gregory M. Mayhew collaborates with scholars based in United States, Netherlands and Germany. Gregory M. Mayhew's co-authors include Jeffery M. Vance, Eden R. Martin, William K. Scott, Yi‐Ju Li, Joelle M. van der Walt, Gaofeng Wang, Stephan Züchner, Mark Stacy, Dana B. Hancock and B.L. Scott and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Gregory M. Mayhew

17 papers receiving 872 citations

Peers

Countries citing papers authored by Gregory M. Mayhew

Since Specialization

Citations

This map shows the geographic impact of Gregory M. Mayhew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory M. Mayhew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory M. Mayhew more than expected).

Fields of papers citing papers by Gregory M. Mayhew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory M. Mayhew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory M. Mayhew. The network helps show where Gregory M. Mayhew may publish in the future.

Co-authorship network of co-authors of Gregory M. Mayhew

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory M. Mayhew. A scholar is included among the top collaborators of Gregory M. Mayhew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory M. Mayhew. Gregory M. Mayhew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Characterization of FGFR Alterations and Activation in Patients with High-Risk Non–Muscle-Invasive Bladder Cancer 2024 ·Clinical Cancer Research ·Joel R. Eisner, (unknown), Yoichiro Shibata, Gregory M. Mayhew, James M. Davison, (unknown), Kirk L. Pappan, Shibu Thomas, Spyros Triantos, Ademi Santiago-Walker, Mahadi Baig, Michael V. Milburn, (unknown), Tahlita C.M. Zuiverloon	2
2	Abstract 2542: Real-world validation of the PurIST classifier demonstrates enhanced therapy selection for pancreatic ductal adenocarcinoma (PDAC) patients 2024 ·Cancer Research ·Stéphane Wenric, James M. Davison, John Guittar, Gregory M. Mayhew, (unknown), (unknown), Seung Won Hyun, Kyle A. Beauchamp, (unknown), Vincent Chung, Tanios Bekaii‐Saab, Charles M. Perou	0
3	Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study 2023 ·Clinical Cancer Research ·Joel R. Eisner, Gregory M. Mayhew, James M. Davison, (unknown), Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jeffrey M. Conroy, Michael V. Milburn, D. Neil Hayes, Kathryn F. Mileham	0
4	Distinct Predictive Immunogenomic Profiles of Response to Immune Checkpoint Inhibitors and IL2: A Real-world Evidence Study of Patients with Advanced Renal Cancer 2022 ·Cancer Research Communications ·Joel R. Eisner, (unknown), Gregory M. Mayhew, Yoichiro Shibata, Yuelong Guo, Carol Farhangfar, Farhang Farhangfar, Joshua M. Uronis, Jill M. Mooney, Michael V. Milburn, David Foureau, Richard L. White, Asim Amin, Marcos E. Milla	1
5	Mesenchymal gene expression subtyping analysis for early-stage human papillomavirus-negative head and neck squamous cell carcinoma reveals prognostic and predictive applications 2022 ·Frontiers in Oncology ·Gregory M. Mayhew, Joshua M. Uronis, D. Neil Hayes, José P. Zevallos	2
6	Abstract A002: Purity Independent Subtyping of Tumor (PurIST): Real-world data validation of a pancreatic ductal adenocarcinoma (PDAC) gene expression classifier and its prognostic implications 2022 ·Cancer Research ·Stéphane Wenric, James M. Davison, (unknown), Gregory M. Mayhew, (unknown), Hyunseok P. Kang, (unknown), Vincent Chung, Tanios Bekaii‐Saab, Charles M. Perou	2
7	Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience 2021 ·British Journal of Cancer ·Tracy L. Rose, William H. Weir, Gregory M. Mayhew, Yoichiro Shibata, Patrick Eulitt, Joshua M. Uronis, Mi Zhou, Matthew E. Nielsen, Angela B. Smith, Michael Woods, Michele C. Hayward, Ashley H. Salazar, Matthew I. Milowsky, Sara E. Wobker, Katrina McGinty, (unknown), Joel R. Eisner, William Y. Kim	108
8	Predictive value of fibroblast growth factor receptor (FGFR) alterations on anti-PD-(L)1 treatment outcomes in patients (Pts) with advanced urothelial cancer (UC): Pooled analysis of real-world data. 2020 ·Journal of Clinical Oncology ·William Y. Kim, Tracy L. Rose, Florian Roghmann, Markus Eckstein, (unknown), Friedemann Zengerling, Danijel Sikic, Johannes Breyer, Christian Bolenz, Arndt Hartmann, Gregory M. Mayhew, Yoichiro Shibata, Joshua M. Uronis, (unknown), (unknown), Qi Xia, (unknown), Ademi Santiago-Walker, Philipp Erben, (unknown)	4
9	Fibroblast growth factor receptor status and response to immune checkpoint inhibition in metastatic urothelial cancer. 2019 ·Journal of Clinical Oncology ·Tracy L. Rose, Michele C. Hayward, Ashley H. Salazar, Patrick Eulitt, Katrina McGinty, (unknown), Sara E. Wobker, Young E. Whang, (unknown), Mary Dunn, Daniel J. Crona, Yoichiro Shibata, Joshua M. Uronis, Gregory M. Mayhew, Matthew I. Milowsky, William Y. Kim	5
10	Lung Adenocarcinoma and Squamous Cell Carcinoma Gene Expression Subtypes Demonstrate Significant Differences in Tumor Immune Landscape 2017 ·Journal of Thoracic Oncology ·Hawazin Faruki, Gregory M. Mayhew, Jonathan S. Serody, D. Neil Hayes, Charles M. Perou, Myla Lai-Goldman	118
11	Validation of the Lung Subtyping Panel in Multiple Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Lung Tumor Gene Expression Data Sets 2015 ·Archives of Pathology & Laboratory Medicine ·Hawazin Faruki, Gregory M. Mayhew, Cheng Fan, Matthew D. Wilkerson, Paul Park, Lauren Kam-Morgan, Marcia Eisenberg, Bruce Horten, D. Neil Hayes, Charles M. Perou, Myla Lai-Goldman	4
12	Space–time clustering and the permutation moments of quadratic forms 2013 ·Stat ·(unknown), Gregory M. Mayhew, Zhibin Sun, Xiaolin Xu, Fei Zou, Fred A. Wright	5
13	Genome-wide Linkage Screen in Familial Parkinson Disease Identifies Loci on Chromosomes 3 and 18 2009 ·The American Journal of Human Genetics ·Xiaoyi Gao, Eden R. Martin, Yutao Liu, Gregory M. Mayhew, Jeffery M. Vance, William K. Scott	8
14	Gene‐Gene Interaction Between FGF20 and MAOB in Parkinson Disease 2008 ·Annals of Human Genetics ·Xiaoyi Gao, William K. Scott, (unknown), Gregory M. Mayhew, Yi‐Ju Li, Jeffery M. Vance, Eden R. Martin	19
15	Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-Synuclein 2008 ·The American Journal of Human Genetics ·Gaofeng Wang, Joelle M. van der Walt, Gregory M. Mayhew, Yi‐Ju Li, Stephan Züchner, William K. Scott, Eden R. Martin, Jeffery M. Vance	360
16	Pesticide exposure and risk of Parkinson's disease: A family-based case-control study 2008 ·BMC Neurology ·Dana B. Hancock, Eden R. Martin, Gregory M. Mayhew, Jeffrey M. Stajich, (unknown), Mark Stacy, B.L. Scott, Jeffery M. Vance, William K. Scott	215
17	Investigation of the PARK10 Gene in Parkinson Disease 2007 ·Annals of Human Genetics ·Yi‐Ju Li, Jie Deng, Gregory M. Mayhew, (unknown), Xiang Huo, Jeffery M. Vance	13
18	Family‐based case–control study of MAOA and MAOB polymorphisms in Parkinson disease 2006 ·Movement Disorders ·Sun Jung Kang, William K. Scott, Yi‐Ju Li, Michael A. Hauser, Joelle M. van der Walt, Kenichiro Fujiwara, Gregory M. Mayhew, Sandra G. West, Jeffery M. Vance, Eden R. Martin	27
19	P1–361: Mapping genes affecting age–at–onset of Alzheimer's disease in the chromosome 8 2006 ·Alzheimer s & Dementia ·Jeffery M. Vance, Jie Deng, Gregory M. Mayhew, (unknown), Margaret A. Pericak‐Vance, Yi‐Ju Li	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhitao Han Breakdown of academic impact, for papers by Núria Llecha Breakdown of academic impact, for papers by Bong-Seon Kim Breakdown of academic impact, for papers by Nedret Altıok Breakdown of academic impact, for papers by Meltem Müftüoğlu Breakdown of academic impact, for papers by Huan Xiong Breakdown of academic impact, for papers by J.P. Julien Breakdown of academic impact, for papers by Hajime Abe